Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Efe Eworuke

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
American Journal of Obstetrics and Gynecology|November 29, 2020
Incidence of uterine bleeding following oral anticoagulant use in Food and Drug Administration's Sentinel SystemAbby Anderson, Audrey Gassman, Laura Hou, et al.
Journal of the American College of Cardiology|January 25, 2023
Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone InhibitorsEfe Eworuke, Emily C Welch, Nicole Haug, et al.
American Journal of Epidemiology|June 2, 2024
A simulation-based bias analysis to assess the impact of unmeasured confounding when designing nonrandomized database studiesRishi J Desai, Marie C Bradley, Hana Lee, et al.
Pharmacoepidemiology and Drug Safety|August 1, 2022
A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulantsAdebola Ajao, Austin Cosgrove, Efe Eworuke, et al.
Pharmacoepidemiology and Drug Safety|November 5, 2022
Social media for early characterization of pandemic symptoms: A qualitative analysis of patient-reported COVID-19 experiencesMelissa Khashei, Scott Janiczak, Christopher St Clair, et al.
American Journal of Epidemiology|July 25, 2024
Identifying pediatric hypertension in observational data: comparing clinical and claims cohorts in real-world dataCasie E Horgan, Jillian Burk, Efe Eworuke, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2016
Strategies addressing inadequate information on health factors in pharmacoepidemiology studies relying on healthcare databases: commentary from a public workshopEfe Eworuke, Fadia Shaya, David J Graham, et al.
Pharmacoepidemiology and Drug Safety|October 13, 2024
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer RiskCheng Chen, Efe Eworuke, Ashish Rai, et al.
Drug Safety|May 20, 2021
Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and WarfarinEfe Eworuke, Laura Hou, Rongmei Zhang, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 8, 2023
Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 codingJummai Apata, Jennifer G Lyons, Marie C Bradley, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
American Journal of Obstetrics and Gynecology|November 29, 2020
Incidence of uterine bleeding following oral anticoagulant use in Food and Drug Administration's Sentinel SystemAbby Anderson, Audrey Gassman, Laura Hou, et al.
Journal of the American College of Cardiology|January 25, 2023
Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone InhibitorsEfe Eworuke, Emily C Welch, Nicole Haug, et al.
American Journal of Epidemiology|June 2, 2024
A simulation-based bias analysis to assess the impact of unmeasured confounding when designing nonrandomized database studiesRishi J Desai, Marie C Bradley, Hana Lee, et al.
Pharmacoepidemiology and Drug Safety|August 1, 2022
A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulantsAdebola Ajao, Austin Cosgrove, Efe Eworuke, et al.
Pharmacoepidemiology and Drug Safety|November 5, 2022
Social media for early characterization of pandemic symptoms: A qualitative analysis of patient-reported COVID-19 experiencesMelissa Khashei, Scott Janiczak, Christopher St Clair, et al.
American Journal of Epidemiology|July 25, 2024
Identifying pediatric hypertension in observational data: comparing clinical and claims cohorts in real-world dataCasie E Horgan, Jillian Burk, Efe Eworuke, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2016
Strategies addressing inadequate information on health factors in pharmacoepidemiology studies relying on healthcare databases: commentary from a public workshopEfe Eworuke, Fadia Shaya, David J Graham, et al.
Pharmacoepidemiology and Drug Safety|October 13, 2024
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer RiskCheng Chen, Efe Eworuke, Ashish Rai, et al.
Drug Safety|May 20, 2021
Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and WarfarinEfe Eworuke, Laura Hou, Rongmei Zhang, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 8, 2023
Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 codingJummai Apata, Jennifer G Lyons, Marie C Bradley, et al.
Pageof 5